Details for 2016837818

Up to date per 03.04.2026

Actions

Title / Product Name

STABILE ANTI-IFNAR1-FORMULIERUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016837818

EP Publication Number

3337502

E-Number

1283234

Language

PCT Number

US16047506

Publication Date

27.06.2018 A

24.06.2020 B1

Registration Date

24.06.2020

AT Publication Date

15.07.2020

Application Date

18.08.2016

Registration Number

Priorities

19.08.2015

201562207164 P

IPC

A61K 39/00 20060101AFI20181220BHEP

Maximum Duration of Protection

18.08.2036

Owner

AstraZeneca AB 151 85 SödertäljeSE

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

DEPAZ, Robertoc/o Medimmune LLC One Medimmune Way Gaithersburg, MD 20878US

DEJESUS, Nataliec/o Medimmune LLC One Medimmune Way Gaithersburg, MD 20878US

BEE, Jaredc/o Medimmune LLC One Medimmune Way Gaithersburg, MD 20878US

Information about Fees